Oral complications such as osteonecrosis of the jaw (ONJ) are rare in women taking medications for postmenopausal osteoporosis, according to a study published in the Journal of Clinical Endocrinology & Metabolism. Researchers used data from the seven-year FREEDOM Extension trial to assess information on oral procedures and cases of ONJ in women taking denosumab for postmenopausal osteoporosis. They found 45% of patients had at least one invasive dental procedure, but the overall rate of ONJ was low.